Found: 5
Select item for more details and to access through your institution.
Circulating total and H-specific GDF15 levels are elevated in subjects with MASLD but not in hyperlipidemic but otherwise metabolically healthy subjects with obesity.
- Published in:
- Cardiovascular Diabetology, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12933-024-02264-5
- By:
- Publication type:
- Article
Total and H‐specific growth/differentiation factor 15 levels are unaffected by liraglutide or naltrexone/bupropion administration.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 8, p. 3147, doi. 10.1111/dom.15642
- By:
- Publication type:
- Article
Circulating levels of proglucagon‐derived peptides are differentially regulated by the glucagon‐like peptide‐1 agonist liraglutide and the centrally acting naltrexone/bupropion and can predict future weight loss and metabolic improvements: A 6‐month long interventional study
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2561, doi. 10.1111/dom.15141
- By:
- Publication type:
- Article
Postprandial Glucose and Gastrointestinal Hormone Responses of Healthy Subjects to Wheat Biscuits Enriched with L-Arginine or Branched-Chain Amino Acids of Plant Origin.
- Published in:
- Nutrients, 2022, v. 14, n. 20, p. 4381, doi. 10.3390/nu14204381
- By:
- Publication type:
- Article
How Important Is Eating Rate in the Physiological Response to Food Intake, Control of Body Weight, and Glycemia?
- Published in:
- Nutrients, 2020, v. 12, n. 6, p. 1734, doi. 10.3390/nu12061734
- By:
- Publication type:
- Article